Literature DB >> 26015318

Circulating miRNAs as biomarkers for endocrine disorders.

H Butz1,2, N Kinga3, K Racz1,3, A Patocs4,5,6.   

Abstract

Specific, sensitive and non-invasive biomarkers are always needed in endocrine disorders. miRNAs are short, non-coding RNA molecules with well-known role in gene expression regulation. They are frequently dysregulated in metabolic and endocrine diseases. Recently it has been shown that they are secreted into biofluids by nearly all kind of cell types. As they can be taken up by other cells they may have a role in a new kind of paracrine, cell-to-cell communication. Circulating miRNAs are protected by RNA-binding proteins or microvesicles hence they can be attractive candidates as diagnostic or prognostic biomarkers. In this review, we summarize the characteristics of extracellular miRNA's and our knowledge about their origin and potential roles in endocrine and metabolic diseases. Discussions about the technical challenges occurring during identification and measurement of extracellular miRNAs and future perspectives about their roles are also highlighted.

Entities:  

Keywords:  Biomarker; Circulating microRNA; Endocrine tumor

Mesh:

Substances:

Year:  2015        PMID: 26015318     DOI: 10.1007/s40618-015-0316-5

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  105 in total

1.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

Authors:  Evan M Kroh; Rachael K Parkin; Patrick S Mitchell; Muneesh Tewari
Journal:  Methods       Date:  2010-02-08       Impact factor: 3.608

Review 2.  Phenotypic and functional characterization of intestinal epithelial exosomes.

Authors:  J Mallegol; G van Niel; M Heyman
Journal:  Blood Cells Mol Dis       Date:  2005 Jul-Aug       Impact factor: 3.039

3.  miR-15a and miR-16-1 down-regulation in pituitary adenomas.

Authors:  Arianna Bottoni; Daniela Piccin; Federico Tagliati; Andrea Luchin; Maria Chiara Zatelli; Ettore C degli Uberti
Journal:  J Cell Physiol       Date:  2005-07       Impact factor: 6.384

4.  Circulating miRNA profiles in patients with metabolic syndrome.

Authors:  Dwi Setyowati Karolina; Subramaniam Tavintharan; Arunmozhiarasi Armugam; Sugunavathi Sepramaniam; Sharon Li Ting Pek; Michael T K Wong; Su Chi Lim; Chee Fang Sum; Kandiah Jeyaseelan
Journal:  J Clin Endocrinol Metab       Date:  2012-10-02       Impact factor: 5.958

5.  MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network.

Authors:  Jianjun Zhang; Haiyan Guo; Guanxiang Qian; Shengfang Ge; Huifeng Ji; Xiaobo Hu; Wantao Chen
Journal:  Mol Cancer       Date:  2010-08-06       Impact factor: 27.401

6.  MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas.

Authors:  Mayrin Correa-Medina; Valia Bravo-Egana; Samuel Rosero; Camillo Ricordi; Helena Edlund; Juan Diez; Ricardo L Pastori
Journal:  Gene Expr Patterns       Date:  2008-12-24       Impact factor: 1.224

7.  MicroRNAs differentially expressed in ACTH-secreting pituitary tumors.

Authors:  Fernando Colbari Amaral; Natalia Torres; Fabiano Saggioro; Luciano Neder; Hélio Rubens Machado; Wilson Araújo Silva; Ayrton Custódio Moreira; Margaret Castro
Journal:  J Clin Endocrinol Metab       Date:  2008-10-07       Impact factor: 5.958

8.  MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.

Authors:  James C Lee; Jing Ting Zhao; Roderick J Clifton-Bligh; Anthony Gill; Justin S Gundara; Julian C Ip; Anthony Glover; Mark S Sywak; Leigh W Delbridge; Bruce G Robinson; Stanley B Sidhu
Journal:  Cancer       Date:  2013-10-28       Impact factor: 6.860

9.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

10.  Exosomes: secreted vesicles and intercellular communications.

Authors:  Clotilde Théry
Journal:  F1000 Biol Rep       Date:  2011-07-01
View more
  7 in total

Review 1.  Tying malaria and microRNAs: from the biology to future diagnostic perspectives.

Authors:  Mercedes Rubio; Quique Bassat; Xavier Estivill; Alfredo Mayor
Journal:  Malar J       Date:  2016-03-15       Impact factor: 2.979

2.  Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients.

Authors:  Mohamed Bakr Zaki; Ahmed Ibrahim Abulsoud; Ahmed Mohamed Elsisi; Ahmed Soliman Doghish; Ossama Abd Elmotaal Mansour; Ashraf Ismail Amin; Mahmoud Ahmed Elrebehy; Mohamed Yousef Mohamed; Mohamed Ahmed Goda
Journal:  Diabetes Metab Syndr Obes       Date:  2019-05-06       Impact factor: 3.168

3.  Genetic Indices Relationship to Hyperglycemia-associated Biomarkers: Consistency with miRNA Expression in Egyptian Children with T1DM

Authors:  Naglaa Fathy Barseem; Marwa Mohamed Mahasab; Ibrahem Fathy Zaed; Aya Eldesoky A. Said; Eman Masoud Abd El Gayed
Journal:  J Clin Res Pediatr Endocrinol       Date:  2021-12-20

Review 4.  MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor Ligands.

Authors:  Daniel G Henriques; Elisa B Lamback; Romulo S Dezonne; Leandro Kasuki; Monica R Gadelha
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

5.  Acute strength training promotes responses in whole blood circulating levels of miR-146a among older adults with type 2 diabetes mellitus.

Authors:  Gilberto Santos Morais Junior; Vinicius Carolino Souza; Wilcelly Machado-Silva; Adriane Dallanora Henriques; Andressa Melo Alves; Danilo Barbosa Morais; Otávio Toledo Nóbrega; Ciro José Brito; Roberto Jerônimo Dos Santos Silva
Journal:  Clin Interv Aging       Date:  2017-09-15       Impact factor: 4.458

6.  MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis.

Authors:  Taís S Assmann; Mariana Recamonde-Mendoza; Bianca M De Souza; Daisy Crispim
Journal:  Endocr Connect       Date:  2017-10-06       Impact factor: 3.335

7.  The Role of miR-342 in Vascular Health. Study in Subclinical Cardiovascular Disease in Mononuclear Cells, Plasma, Inflammatory Cytokines and PANX2.

Authors:  Sabina L Ray; David J Coulson; Megan Li Yuen Yeoh; Alice Tamara; Jevi Septyani Latief; Sherin Bakhashab; Jolanta U Weaver
Journal:  Int J Mol Sci       Date:  2020-09-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.